Back


18/09/2018
HORAMA completes its 22.5 million euros “Series B” financing round
Horama (www.horama.fr), a French biotech company based in Paris and Nantes, which specialises in gene therapy for the treatment of rare genetic diseases in ophthalmology, announces today that the Belgian fund V-Bio Ventures joins the company’s “Series B” financing round. Willem Broekaert, Managing Partner at V-Bio Ventures, will be appointed to the Horama Board. [...]

Download the pdf file





X

X